Last call to get patients involved in the GRIDD study
The online survey takes 10-20 minutes to complete and is open only until December 31, 2023.
top of page
NEWS
- Dec 20, 2023
Chiesi Global Rare Diseases receives FDA approval for FILSUVEZ® topical gel for the treatment of EB
FILSUVEZ topical gel is indicated for the treatment of partial thickness wounds in patients 6 months and older with Junctional and...
- Aug 14, 2023
DEBRA UK announces its first approved drug repurposing clinical trial
This clinical trial will see an existing licensed treatment for psoriasis clinically tested on children and adults with severe EB simplex
- May 1, 2023
New clinical trials online tool goes live
EB Research Network has created a new online tool to make tracking of clinical trials easier
bottom of page